Myopia in Adults - Optometry Advisor
Nov 1, 2024 · Axial Elongation in Adult Myopia . Regular eye exams are important for all adults, particularly those experiencing myopia progression. During these visits, it is important for clinicians to measure axial length, due to its association with pathologic myopia. 3 An optical biometer can best measure axial length changes, but not all practices have one. . Among optometry practices that do utilize ...
FDA Alerts: New Optometry Drugs and Devices
3 days ago · In the last month, the US Food and Drug Administration (FDA) has approved a visual field analyzer that uses only objective parameters to determine visual field loss, cleared a mapping and data module for a corneal optical coherence tomography (OCT) device, granted rare pediatric disease designation for a novel gene therapy for inherited retinal dystrophy, and approved a generic equivalent for ...
Ocular Surface Disease Drugs Show Real-World Results
1 day ago · Prior to launching perfluorohexyloctane, prescription dry eye treatments were aimed at reducing inflammation and increasing tear production. Even though targeting these areas can be beneficial, they do not specifically address the evaporative component of DED. 5 Perfluorohexyloctane, however, not only treats both the signs and symptoms of dry eye, but targets this element, which previous ...
FDA Alerts: New Optometry Drugs and Devices
Feb 20, 2024 · Drug Regulatory Updates. PL9643: Dry Eye Disease. Palatin Technologies, Inc. has received confirmation from the FDA regarding the acceptability of the protocols and endpoints for signs and symptoms of PL9643 in its phase 3 pivotal clinical trials for dry eye disease (DED). 1 The remaining phase 3 clinical trials, MELODY-2 and MELODY-3, include endpoints related to both signs and symptoms of ...
Optometry in 2024: What to Expect for the New Year
Dec 21, 2023 · Top Achievements of 2023. Some treatments for DED have made their way through the 2023 pipeline and into pharmacies. Meibo ® (Bausch + Lomb) and Xdemvy ® (Tarsus) received FDA approval this year and the drugs have shown promise for treating evaporative DED and Demodex blepharitis, respectively, company press releases from the 2 drug manufacturers claim. 4,5
Approaches to Patient Care in Optometry - Optometry Advisor
Oct 4, 2024 · An optometry student can learn a lot in a lab or clinical research setting, but their contact with patients will ultimately guide their clinical decision-making skills and shape their perspectives, according to Andrew Rixon, OD, FAAO, Diplomate (Glaucoma), this year’s recipient of the Vincent Ellerbrock Clinician Educator Award.
Myopia Control Spectacles for Myopia Management - Optometry …
Dec 6, 2024 · Eye care professionals have come to understand the importance of not only correcting myopia, but slowing its progression within the last few decades; and while the US Food and Drug Administration (FDA) has approved contact lens therapies for treating the disorder, the agency has yet to approve any myopia control spectacles. Today’s “myopia boom” affects patients worldwide, worsening ...
Lens-Based Myopia Control: Know When to Treat and Expect Results
Dec 15, 2023 · Treatments were decided based on the results of this data analysis and patients were monitored every 3 to 6 months for progression, which was defined as 0.25 D or greater myopia spherical equivalent progression (as assessed with cycloplegic autorefraction) or greater than 0.10 mm axial elongation in 6 months. Children who showed progression while on one treatment, received a change in treatment.
Red Light Therapy Provides Myopia Control ... - Optometry Advisor
Nov 22, 2023 · As optometrists struggle with the demand created by an emerging myopia epidemic, repeated low-level red light therapy may provide an alternative to contact lens wear or atropine treatment for slowing axial progression and spherical equivalent refraction (SER). While the treatment has yet to receive US Food and Drug Administration (FDA) approval, it has demonstrated efficacy in clinical trials ...
Optometry Dx: Secondary Retinal Detachment Surgery
Oct 4, 2024 · A pars-plana vitrectomy (PPV) for a tractional retinal detachment involves the removal of vitreous membranes that are causing traction on the retina. There is good evidence of successful reattachment of the retina after surgery. In a meta-analysis and systematic review of studies examining 3839 eyes undergoing PPV for diabetic retinal detachment, there was a 5.9% failure rate of the retina ...